睡眠:改善特发性肺纤维化结局的新靶点
本文综述特发性肺纤维化(IPF)患者睡眠障碍的研究现状,指出IPF患者睡眠结构、睡眠呼吸模式及氧饱和度均显著受损,尤其快速眼动睡眠期更明显,且阻塞性睡眠呼吸暂停(OSA)患病率增高。综述强调治疗睡眠问题与OSA可能改善睡眠质量、生活质量及疾病结局,呼吁医生重视IPF患者OSA的早期诊断并加强相关研究。
要点
- IPF患者睡眠显著受损,睡眠结构改变、呼吸模式异常及氧饱和度下降,快速眼动睡眠期尤为脆弱。
- IPF患者中OSA患病率增高,进一步恶化本已因疾病受损的睡眠质量。
- 治疗睡眠问题及OSA可能改善睡眠、生活质量及疾病结局,需重视IPF患者OSA早期诊断。
核心结论
- IPF患者睡眠显著受损,治疗睡眠问题及OSA可能改善睡眠质量、生活质量及疾病结局。
研究设计与样本
- 本文为综述,总结IPF患者睡眠相关研究,未报告系统检索范围。
主要发现
- IPF患者睡眠结构改变、睡眠呼吸模式变化,氧饱和度下降主要发生在快速眼动睡眠期。
- IPF患者中OSA患病率增高,并在疾病本身所致睡眠质量恶化中起重要作用。
临床怎么用
- 呼吸科医生应提高对IPF患者OSA早期诊断的意识,并关注睡眠问题对疾病结局的影响。
局限性
- IPF患者睡眠障碍与药物疗效的相互作用仍研究不足。
- 既往医生多仅处理日间致残症状,忽视睡眠改变或共病睡眠障碍的可能重要作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Idiopathic pulmonary fibrosis (IPF) is the most common type of interstitial pneumonia but remains a disease with a poor outcome. Two drugs, pirfenidone and nintedanib, have shown promising results at stalling disease progression; however, the interplay of sleep disruption or sleep disorders overall and in relation to medication effectiveness remains understudied. In the past, there was limited interest in the role of sleep in patients with IPF. Treating physicians tended to address only the daily disabling symptoms while disregarding the possible significant role of sleep alterations or coexisting sleep disorders. During the past few years, there has been more research related to sleep disturbances in patients with IPF and their possible role in sleep and overall life quality, disease progression, and outcome. In summary, sleep in patients with IPF is significantly impaired, with alterations in sleep architecture, changes in sleep breathing pattern, and decreases in oxygen saturation mainly during vulnerable rapid eye movement sleep. There also is evidence that OSA has an increased prevalence in these patients, playing an important role in the already worse sleep quality related to the disease itself. The focus of this review is not only to present current data related to sleep in patients with IPF but also to point out that therapy for sleep problems and OSA is likely to improve sleep and life quality as well as disease outcome. The main priority remains to increase awareness among treating physicians about early diagnosis of OSA in patients with IPF and to emphasize the need for intense future research, especially on the role of intermittent hypoxia superimposed on chronic hypoxia during sleep in patients with IPF.
引用
- Mermigkis C, Bouloukaki I, Schiza SE, et al. Sleep as a New Target for Improving Outcomes in Idiopathic Pulmonary Fibrosis. Chest. 2017. PMID: 28774636. doi:10.1016/j.chest.2017.07.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。